CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I Study of Romidepsin (ISTODAX®) Plus ICE for Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01590732
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:09.111988+00:00
Published At: 2018-09-19T00:00:00+00:00
Record Updated At: 2018-09-19
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Mycosis Fungoides", "Recurrent Anaplastic Large Cell Lymphoma", "Recurrent Angioimmunoblastic T-Cell Lymphoma", "Recurrent Enteropathy-Associated T-Cell Lymphoma", "Recurrent Hepatosplenic T-Cell Lymphoma", "Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified", "Refractory Anaplastic Large Cell Lymphoma", "Refractory Angioimmunoblastic T-Cell Lymphoma", "Refractory Enteropathy-Associated T-Cell Lymphoma", "Refractory Hepatosplenic T-Cell Lymphoma", "Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-09-19"
protocolSection.identificationModule.nctId: "NCT01590732"
protocolSection.identificationModule.officialTitle: "Phase I Study of Romidepsin (ISTODAX\u00ae) Plus ICE for Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.